Novartis Investigative Site
Stoneham, Massachusetts 02180
0 studies enrolling now · 3 studies all time
What they study most
Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Diabetic Macular Edema
Studies at this site
- Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema — Completed
- Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion — Stopped early
- Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion — Stopped early